Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1823-1829

  Yonemura, Yutaka ^a   Endo, Yoshio ^a   Fujita, Hideto ^a   Fushida, Sachio ^a   Ninomiya, Itasu ^a   Bandou, Etsurou ^a   Taniguchi, Keizou ^a   Miwa, Kouichi ^a   Ohoyama, Sigekazu ^c   Sugiyama, Kazuo ^b   Sasaki, Takuma ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ENDOTHELIAL GROWTH FACTORS; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0032790131     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stanley, K., Stjernsward, J., and Koroltchouk, V. Cancer of the stomach, lung, and breast: mortality trends and control strategies. World Health Stat. Q., 41: 107-114, 1988.
2. Maruyama, K., Gunven, P., Okabayashi, K., Sasako, M., and Kinoshita, T. Lymph node metastases of gastric cancer: general pattern in 1931 patients. Ann. Surg., 210: 596-602, 1989.
3. Yonemura, Y., Katayama, K., Kamata, T., Fushida, S., Segawa, M., Ohoyama, S., Miwa, K., and Miyazaki, I. Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph nodes. Int. Surg., 76: 222-225, 1991.
4. Dent, D. M., Madden, M. V., and Price, S. K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br. J. Surg., 75: 110-112, 1988.
5. Noguchi, Y., Imada, T., Matsumoto, A., Coit, D. G., and Brennan, M. F. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer (Phila.)., 64: 2053-2062, 1989.
6. Murata, Y., Suzuki, S., Sugiyama, S., Hayashi, K., Yamamoto, K., Sasagawa, T., Kitamura, Y., Suzuki, M., Ide, H., Yamada, A., Suzuki, H., and Hanyu, F. Role of ultrasonography in determining treatment for m and sm cancer of GI tract. Depiction of the muscularis mucosa (in Japanese). Jpn. J. Gastroenterol., 26: 2512-2516, 1993.
7. Yonemura, Y., Ninomiya, I., Ohoyama S., Fushida, S., Kimura, H., Tsugawa, K., Kamata, T., Yamaguchi, A., Miyazaki, I., Endou, Y., Tanaka, M., and Sasaki, T. Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer. Oncology, 49: 363-367, 1992.
8. Yonemura, Y., Sugiyama, K., Ninomiya, I., Fushida, S., Tsugawa, K., Hirono, Y., Yamaguchi, A., Miyazaki, I., Endou, Y., Tanaka, M., and Sasaki, T. Evidence of autocrine mechanism in poorly differentiated adenocarcinoma of the stomach. Int. J. Oncol., 2: 643-648, 1993.
9. Kaji, M., Yonemura, Y., Harada, S., Kanako, T., Miwa, K., Miyazaki, I., and Yamamoto, H. Antisense oligonucleotides against c-met mRNA inhibit the growth of human gastric cancer cells. Antisense Res. Dev., 5: 99-100, 1995.
10. Taniguchi, K., Yonemura, Y., Nojima, N., Hirono, Y., Fushida, S., Fujimura, T., Miwa, K., Endou, Y., Yamamoto, H., and Watanabe, H. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer (Phila.)., 82: 2112-2122, 1998.
11. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., and Alitalo, K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (Washington DC), 276: 1423-1425, 1997.
12. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Cancer. Tokyo: Kanehara Shuppan Co., Ltd., 1993.
13. Sato, Y., Mukai, K., Watanabe, S., Goto, M., and Shimosato, Y. The AMeX method: a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am. J. Pathol., 125: 431-435, 1986.
14. Conboy, J. G., Chan, J., Mohandas, N., and Kan, Y. W. Multiple protein 4.1 isoform produced by alternative splicing in human erythroid cells. Proc. Natl. Acad. Sci. USA, 85: 9062-9065, 1988.
15. Galland, F., Karamysheva, A., Pebusque, M., Borg, J., Rottapel, R., Dubreuil, P., Rosnet, O., and Burnbaum, D. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene, 8: 1233-1240, 1993.
16. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
17. Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashita T., Yamashita, J., and Yamamoto, H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem., 270: 28316-28324, 1995.
18. Ng, S., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., and Kedes, L. Evolution of the functional human β-actin gene and its multipseudogene family, conversation of noncoding regions and chromosomal dispersion pseudogenes. Mol. Cell. Biol., 5: 2720-2732, 1985.
19. Schneider, C., Owen, M. J., Banville, D., and Williams, J. G. Primary structure of transferrin receptor deduced from mRNA sequence. Nature (Lond.), 311: 675-678, 1984.
20. Jetsch, M., Kaipainen, A., Joukov, V., Meng, X. M., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (Washington DC), 276: 1423-1425, 1997.
21. Joukov, V., Pajusolo, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. A novel vascular endothelial growth factor, VEGF-C, is a ligands for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15: 290-298, 1996.
22. Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K., and Wilting, J. VEGF and VEGF-C: specific induction of angiogenesis and lymphoangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol., 188: 96-109, 1997.
23. Millauer, B., Wizingmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, P. H., and Ullrich, A. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 71: 835-846, 1993.
24. Yonemura, Y., Nojima, N., Kaji, M., Fujimura, T., Itoh, H., Ninomiya, I., Miyazakai, I., Endou, Y., and Sasaki, Y. T. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer (Phila.)., 76: 941-953, 1995.
25. Liotta, LA. Tumor invasion and metastasis: role of the extracellular matrix. Cancer Res., 46: 1-7, 1986.
26. Hirono, Y., Fushida, S., Yonemura, Y., Yamamoto, H., Watanabe, H., and Raz, A. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br. J. Cancer, 74: 2003-2007, 1996.
27. Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., and Croce, C. M. Molecular cloning of new transforming gene from a chemically transformed human cell line. Nature (Lond.), 311: 29-32, 1984.
28. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., ClaessonWelsh, L., Cao, Y., Saksela, O., Kalkkinen, N., and Alitalo, K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J., 16: 3898-3911, 1997.